UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized multicenter study evaluating Xolair persistence of response after long-term therapy

Journal of allergy and clinical immunology, 2017-07, Vol.140 (1), p.162-169.e2

2017

Volltextzugriff (PDF)

Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma

Journal of allergy and clinical immunology, 2014-06, Vol.133 (6), p.1549-1556

2014

Volltextzugriff (PDF)

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

Journal of allergy and clinical immunology, 2017-05, Vol.139 (5), p.1431-1444

2017

Volltextzugriff (PDF)

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO

Journal of allergy and clinical immunology, 2019-04, Vol.143 (4), p.1629-1633.e2

2019

Volltextzugriff (PDF)

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Journal of allergy and clinical immunology, 2012-08, Vol.130 (2), p.332-342.e10

2012

Volltextzugriff (PDF)

Dupilumab in Adults and Adolescents With Eosinophilic Esophagitis

Pediatrics (Evanston), 2023-12, Vol.152 (Supplement 3), p.S44-S44

Chipps, Bradley E.

2023

Volltextzugriff (PDF)

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Journal of allergy and clinical immunology, 2009-11, Vol.124 (5), p.895-902.e4

2009

Volltextzugriff (PDF)

Dupilumab in Children With Uncontrolled Moderate-to-Severe Asthma

Pediatrics (Evanston), 2022-12, Vol.150 (Supplement 3), p.S55-S55

Chipps, Bradley E.

2022

Volltextzugriff (PDF)

Efficacy and Safety of Itepekimab in Patients With Moderate-to-Severe Asthma

Pediatrics (Evanston), 2022-12, Vol.150 (Supplement 3), p.S55-S56

Chipps, Bradley E.

2022

Volltextzugriff (PDF)

Bronchial thermoplasty: a review of the evidence

Annals of allergy, asthma, & immunology, 2016-02, Vol.116 (2), p.92-98

2016

Volltextzugriff (PDF)

The burden of exacerbations in mild asthma: a systematic review

ERJ open research, 2020-07, Vol.6 (3), p.359

2020

Volltextzugriff (PDF)

Ligelizumab for Chronic Spontaneous Urticaria

Pediatrics (Evanston), 2020-12, Vol.146 (Supplement_4), p.S343-S343

Bradley E, Chipps

2020

Volltextzugriff (PDF)

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

Annals of the American Thoracic Society, 2021-12, Vol.18 (12), p.1978-1987

2021

Volltextzugriff (PDF)

Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. Reply

The New England journal of medicine, 2022-08, Vol.387 (7), p.663-663

2022

Volltextzugriff (PDF)

Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma

Annals of allergy, asthma, & immunology, 2018-05, Vol.120 (5), p.504-511.e4

2018

Volltextzugriff (PDF)

Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Therapeutic advances in respiratory disease, 2024-01, Vol.18, p.17534666241232264-17534666241232264

2024

Volltextzugriff (PDF)

AR101 Oral Immunotherapy for Peanut Allergy

Pediatrics (Evanston), 2019-12, Vol.144 (Supplement_1), p.S31-S31

Chipps, Bradley E.

2019

Volltextzugriff (PDF)

Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY

Therapeutic advances in respiratory disease, 2024-01, Vol.18, p.17534666241254212

2024

Volltextzugriff (PDF)

Economic burden of impairment in children with severe or difficult-to-treat asthma

Annals of allergy, asthma, & immunology, 2011-08, Vol.107 (2), p.110-119.e1

2011

Volltextzugriff (PDF)

Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2014-09, Vol.2 (5), p.544-552.e2

2014

Volltextzugriff (PDF)

The Bela Schick Lecture: if you don't know where you are going, you may end up somewhere else

Annals of allergy, asthma, & immunology, 2015-06, Vol.114 (6), p.440-442

Chipps, Bradley E., MD

2015

Volltextzugriff (PDF)

Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma

Journal of allergy and clinical immunology, 2009-11, Vol.124 (5), p.921-927

2009

Volltextzugriff (PDF)

Feasibility of Using Treatment Response Thresholds for Lung Function and Asthma Symptom Variables As Indicators of Asthma Control in Patients with Moderate to Severe Asthma

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB210-AB210

2016

Volltextzugriff (PDF)

Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations

Pediatrics (Evanston), 2018-12, Vol.142 (Supplement_4), p.S265-S265

Chipps, Bradley E.

2018

Volltextzugriff (PDF)

The Childhood Asthma Control Test∗ : Retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma

Journal of allergy and clinical immunology, 2010-08, Vol.126 (2), p.267-273.e1

2010

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Englisch
(279)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(150)
Science & Technology
(150)
Humans
(111)
Allergy
(106)
Immunology
(94)
Asthma
(86)
Child
(58)
Pediatrics
(51)
Asthma - Drug Therapy
(50)
Male
(50)
Female
(48)
Adolescent
(45)
Allergy And Immunology
(37)
Adult
(36)
Anti-Asthmatic Agents - Therapeutic Use
(32)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Respiratory System
(28)
Patients
(27)
Quality Of Life
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A randomized multicenter study evaluating Xolair persistence of response after long-term therapy

Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Dupilumab in Adults and Adolescents With Eosinophilic Esophagitis

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Dupilumab in Children With Uncontrolled Moderate-to-Severe Asthma

Efficacy and Safety of Itepekimab in Patients With Moderate-to-Severe Asthma

Bronchial thermoplasty: a review of the evidence

The burden of exacerbations in mild asthma: a systematic review

Ligelizumab for Chronic Spontaneous Urticaria

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. Reply

Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma

Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

AR101 Oral Immunotherapy for Peanut Allergy

Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY

Economic burden of impairment in children with severe or difficult-to-treat asthma

Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma

The Bela Schick Lecture: if you don't know where you are going, you may end up somewhere else

Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma

Feasibility of Using Treatment Response Thresholds for Lung Function and Asthma Symptom Variables As Indicators of Asthma Control in Patients with Moderate to Severe Asthma

Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations

The Childhood Asthma Control Test∗ : Retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma

Suchergebnisse filtern